MYO vs UNH

MYO exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across nearly all health metrics. Despite a high gross margin of 65.7%, the company suffers from negative revenue growth (-5.90%) and a catastrophic year-over-year EPS decline of 800%. While analyst target prices ($4.32) suggest a massive upside, this is completely decoupled from the current financial reality of negative profitability and a bearish technical trend. The company is currently a high-risk micro-cap with deteriorating fundamentals.

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.